Susquehanna International Group’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
VCM
LG
Susquehanna International Group's CLPT Position: Q1 2026 in Review
Susquehanna International Group reduced its ClearPoint Neuro (CLPT) stake by 9.5% in Q1 2026, selling an estimated $180K and leaving 136,284 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #7336.
Susquehanna International Group first reported a position in CLPT in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.83M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.
- Susquehanna International Group held 136,284 shares of ClearPoint Neuro worth $1.24M as of Q1 2026.
- Susquehanna International Group sold 14,272 ClearPoint Neuro shares in Q1 2026, an estimated $180K.
- ClearPoint Neuro made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7336 holding.
- Susquehanna International Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 18 quarters since.
- Susquehanna International Group's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
- 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.